Botanical species · safety record

Melia azedarach

The EFSA Compendium of Botanicals holds 11 constituent measurements and 7 adverse-effect records for Melia azedarach. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Melia azedarach L.

11Constituent measurements
7Safety records
10Cited sources
111Licensed products (Canada)

Also recorded as

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 111 licensed products naming Melia azedarach as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry

Source material stated

  • Fruit
  • Leaf
  • Stem bark

What the records describe

Constituents measured

  • Limonoids5
  • 4-hydroxybenzaldehyde1
  • 4-hydroxybenzoic acid1
  • Hydroxymethylfurfural1
  • Lignans1
  • Medioresinol1
  • Pinoresinol1

Plant parts

  • Unspecified9
  • Fruit unspecified5
  • Bark2
  • Roots and other underground parts2

Preparations

  • Solvent extraction12

Effect types

  • Neurotoxicity3
  • Digestive2
  • Musclo-skeletal1
  • Reproductive1

Target tissues

  • Neurologic3
  • Digestive2

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
LimonoidsFruit unspecifiedSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
LimonoidsRoots and other underground partsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
LimonoidsBarkSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
LimonoidsBarkSolvent extractionUnspecifiedResolve DOI
LimonoidsRoots and other underground partsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
4-hydroxybenzaldehydeUnspecifiedSolvent extractionUnspecifiedNo resolvable identifier
4-hydroxybenzoic acidUnspecifiedSolvent extractionUnspecifiedNo resolvable identifier
HydroxymethylfurfuralUnspecifiedSolvent extractionUnspecifiedNo resolvable identifier
LignansUnspecifiedSolvent extractionUnspecifiedNo resolvable identifier
MedioresinolUnspecifiedSolvent extractionUnspecifiedNo resolvable identifier
PinoresinolUnspecifiedSolvent extractionUnspecifiedNo resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
DigestiveDigestiveUnspecifiedAnimals (as animal)Case reportResolve DOI
DigestiveDigestiveFruit unspecifiedCase reportResolve DOI
Musclo-skeletalUnspecifiedAnimals (as animal)Case reportResolve DOI
NeurotoxicityNeurologicUnspecifiedAnimals (as animal)Case reportResolve DOI
NeurotoxicityNeurologicFruit unspecifiedDog (as animal)Case reportResolve DOI
NeurotoxicityNeurologicFruit unspecifiedCase reportResolve DOI
ReproductiveFruit unspecifiedSolvent extractionRat (as animal)Reproduction toxicityNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Ferreiro, D., Orozco, J. P., Miron, C., Real, T., Hernandez-Moreno, D., Soler, F., Perez-Lopez, M. Chinaberry Tree (Melia azedarach) Poisoning in Dog: A Case Report. Topics in companion animal medicine, 2010, vol. 25, no. 1, p. 64-67. DOI
  2. Cooper, Ross G. Poisoning in ostriches following ingestion of toxic plants - field observations. TROPICAL ANIMAL HEALTH AND PRODUCTION, 2007, vol. 39, no. 6, p. 439-442. DOI
  3. Botha, C. J., Penrith, M. -L. Poisonous plants of veterinary and human importance in southern Africa. JOURNAL OF ETHNOPHARMACOLOGY, 2008, vol. 119, no. 3, p. 549-558. DOI
  4. Roop, J.K., Dhaliwal, P.K. Effect of Melia azedarach Linn seed extract on estrous cycle and reproductive performance in female rats. International journal of pharmtech research, 2015, vol. 8, no. 2, p. 273-279.
  5. Xie, F., Zhang, M., Zhang, C.-F., Wang, Z.-T., Yu, B.-Y. Studies on chemical constituents in fruit of Melia toosendan. Chinese pharmaceutical journal, 2008, vol. 43, no. 14, p. 1066-1069.
  6. Zhang, Qiong., Zhang, Yong-Gang., Li, Qing-Shan., Min, Zhi-Da. Two New Nimbolinin-Type Limonoids from the Fruits of Melia toosendan. Helvetica chimica acta, 2016, vol. 99, no. 6, p. 462-465. DOI
  7. Fukuyama, Yoshiyasu., Nakaoka, Momoko., Yamamoto, Tomoko., Takahashi, Hironobu., Minami, Hiroyuki. Degraded and oxetane-bearing limonoids from the roots of Melia azedarach. Chemical & pharmaceutical bulletin, 2006, vol. 54, no. 8, p. 1219-1222. DOI
  8. Yuan, Chun-Mao., Zhang, Yu., Tang, Gui-Hua., Li, Yan., He, Hong-Ping., Li, Shi-Fei., Hou, Li., Li, Xing-Yao., Di, Ying-Tong., Li, Shun-Lin., Hua, Hui-Ming., Hao, Xiao-Jiang. Cytotoxic Limonoids from Melia azedarach. Planta medica, 2013, vol. 79, no. 2, p. 163-168. DOI
  9. Li, MF., Shi, YL. Toosendanin interferes with pore formation of botulinum toxin type A in PC12 cell membrane . Acta pharmacologica sinica, 2006, vol. 27, no. 1, p. 66-70. DOI
  10. Nakatani, M., Huang, RC., Okamura, H., Iwagawa, T., Tadera, K. Degraded limonoids from Melia azedarach. Phytochemistry, 1998, vol. 49, no. 6, p. 1773-1776. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue